Exchange Approves KOSDAQ New Listings for GFC Life Sciences and Kai Biotech
[Asia Economy Reporter Son Sunhee] The Korea Exchange announced on the 20th that it has approved the new listings of two companies, 'GFC Saengmyeong Science' and 'Kai Biotech,' on the KONEX market. Trading will commence from the 23rd.
GFC Saengmyeong Science is a cosmetics manufacturing company established in June 2002. As of last year, it recorded annual sales of 13.737 billion KRW, operating profit of 1.379 billion KRW, and net profit of 1.617 billion KRW. The valuation price is 17,000 KRW, and the par value per share is 500 KRW.
Kai Biotech is a pharmaceutical manufacturing company established in December 2012. As of last year, it reported annual sales of 2.081 billion KRW, operating loss of 470 million KRW, and net loss of 545 million KRW. The valuation price is 22,000 KRW, and the par value per share is 5,000 KRW.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
The listing eligibility reports for both companies can be accessed through the Korea Exchange Electronic Disclosure System website.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
